Xianzhi Xu
Overview
Explore the profile of Xianzhi Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang Z, Hou S, Gao K, Liu Y, Zhang N, Fang Z, et al.
Adv Sci (Weinh)
. 2024 Jul;
11(35):e2404119.
PMID: 39005231
l-2-Hydroxyglutarate (l-2-HG) is a functionally compartmentalized metabolite involved in various physiological processes. However, its subcellular distribution and mitochondrial transport remain unclear owing to technical limitations. In the present study, an...
2.
Zhu R, Mao Y, Xu X, Li Y, Zheng J
Anticancer Drugs
. 2024 Mar;
35(6):492-500.
PMID: 38477942
The resistance of oral squamous cell carcinoma (OSCC) cells to cisplatin remains a tough nut to crack in OSCC therapy. Homeobox A1 (HOXA1) overexpression has been detected in head and...
3.
Xu X, Mao Y, Feng Z, Dai F, Gu T, Zheng J
Oncol Rep
. 2024 Jan;
51(2).
PMID: 38186303
Head and neck squamous cell carcinoma (HNSCC) is currently one of the most common malignancies with a poor prognosis worldwide. Meanwhile, small ubiquitin‑like modifier (SUMO) specific peptidase 1 (SENP1) was...
4.
Dai F, Xu X, Zhou C, Li C, Tian Z, Wang Z, et al.
Front Cardiovasc Med
. 2023 Dec;
10:1275710.
PMID: 38094123
Background: Acute ST-segment elevation myocardial infarction (STEMI) patients after primary PCI were readmitted for revascularization due to non-culprit lesion (NCL) progression. Objective: To develop and validate a nomogram that can...
5.
Yang S, Shi X, Liu W, Wang Z, Li R, Xu X, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1294909.
PMID: 38027163
Background: The triglyceride glucose-body mass index (TyG-BMI) is a surrogate indicator of insulin resistance. However, the association of TyG-BMI with heart failure (HF) in individuals with diabetes mellitus or prediabetes...
6.
Yang S, Dai F, Wang Z, Li R, Xu X, Li C, et al.
BMC Public Health
. 2023 Sep;
23(1):1862.
PMID: 37752456
Background: In previous studies, sun-protective behaviors increased cardiovascular incidence. Our present article is to further analyze the potential relationship between sun-protective behaviors (staying in the shade, wearing long-sleeved clothing, and...
7.
Xu X, Dai F, Mao Y, Zhang K, Qin Y, Zheng J
Front Pharmacol
. 2023 Sep;
14:1242488.
PMID: 37727388
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality worldwide. Platinum-based chemotherapy is standard-of-care but has limitations including toxicity and resistance. Metal complexes of gold, ruthenium, and...
8.
Liu T, Xuan H, Yin J, Wang L, Wang C, Xu X, et al.
J Multidiscip Healthc
. 2023 Jan;
16:63-73.
PMID: 36660037
Objective: Our purpose was to explore the relationship between triglyceride glucose (TyG) index and the risk of new-onset hypertension in Chinese individuals aged ≥45 years. Methods: From 2011 to 2018,...
9.
Xu X, Xu R, Hou S, Kang Z, Lu C, Wang Q, et al.
Biosensors (Basel)
. 2022 Dec;
12(12).
PMID: 36551077
Selective detection of l-lactate levels in foods, clinical, and bacterial fermentation samples has drawn intensive attention. Many fluorescent biosensors based on non-stereoselective recognition elements have been developed for lactate detection....
10.
Wang L, Liu T, Wang C, Xuan H, Xu X, Yin J, et al.
BMC Cardiovasc Disord
. 2022 Aug;
22(1):386.
PMID: 36030211
Introduction: To develop and validate clinical evaluators that predict adverse left ventricular remodeling (ALVR) in non-ST-elevation myocardial infarction (NSTEMI) patients after primary percutaneous coronary intervention (PCI). Methods: The retrospective study...